MedTrace Logo

Evaluation of Liver Disease in Individuals Attending Alcohol Abuse Treatment - a Randomized Controlled Pilot Trial

NCT05244720 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2024-05-13

No results posted yet for this study

Summary

This pilot study aims to evaluate the feasibility of a non-blinded randomized controlled trial with a parallel group design of an invitation to an evaluation of liver disease (intervention) compared to standard care with no invitation, among individuals in alcohol abuse treatment.

Conditions

Interventions

DIAGNOSTIC_TEST

Fibroscan

A percutaneous scan, that measures shear wave velocity. It estimates liver stiffness.

DIAGNOSTIC_TEST

Blood samples

Blood samples to asses the function of liver, kidney and bone marrow, as well as nutrition/vitamin status.

Sponsors & Collaborators

  • Zealand University Hospital

    lead OTHER

Principal Investigators

  • Gro Askgaard, PhD · Department of Medicine, Zealand University Hospital

  • Lone Madsen, PhD · Department of Medicine, Zealand University Hospital

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-11-01
Primary Completion
2022-09-30
Completion
2022-09-30

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05244720 on ClinicalTrials.gov